Lombard Medical and MicroPort announce strategic partnership and investment

Lombard Medical and MicroPort Scientific Corporation announced a strategic partnership and $15 million investment by MicroPort, including exclusive marketing rights for Aorfix and Altura stent grafts in China and Brazil, and a component supply agreement.

“The strategic partnership with MicroPort benefits all Lombard stakeholders, including physicians and their patients, our employees and, we believe, our shareholders.”vascularnews.com

• 1 source
• vascularnews.comLombard Medical and MicroPort announce strategic partnership and investment agreement - Vascular NewsDec 19, 2016

Summarized from public sources; check the original articles before acting on it.